Clin2
NCT07086794Possibly a fitRecruiting

Testing if pentoxifylline helps reduce cocaine use

Cocaine Use Disorder

Treatments studied

Part of Mental health clinical trials.

This study tests whether a medication called pentoxifylline can reduce cocaine use in people who smoke or inject cocaine but aren't ready to stop. You'll receive either pentoxifylline or a placebo to see if it helps control cravings or use.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
30 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old
  • You have used cocaine by smoking or injecting recently (confirmed by a urine test)
  • You are not currently seeking treatment to stop drug use
  • You have no major medical or mental health conditions besides cocaine use disorder
  • Your heart test (ECG) is normal
  • If female, you must use effective birth control and not be pregnant or breastfeeding
  • You have no known allergies to pentoxifylline
  • You have no history of head injury, seizures, brain tumors, or family history of seizures
  • You can speak and read English

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05529927Recruiting· Phase 2
Dexamphetamine given long-acting to reduce cocaine use

This Phase 2 study tests whether a long-acting form of dexamphetamine can reduce cocaine use in people with moderate to severe cocaine use disorder. It also checks safety, including heart and mental health side effects, while you attend study visits regularly.

The Hague
NCT05008146Recruiting· Early Phase 1
Brain imaging study for cocaine use disorder interactions

This early-phase study uses brain imaging to understand how cocaine use disorder affects brain function. It may help researchers learn more about brain pathways involved in craving and treatment targets.

Pittsburgh, Pennsylvania
NCT07091877Recruiting
Cocaine use and brain response study

This study looks at how cravings for cocaine change over time in people who have recently stopped using. Researchers will measure brain activity to understand this process better.

New York, New York
NCT07313371Recruiting· Phase 4
Clonidine for reducing cravings in cocaine and crack users

This trial tests whether the medication clonidine can help reduce cravings for people hospitalized with cocaine or crack use disorder. You must be staying in a specific hospital ward and be able to take pills by mouth.

São Paulo, São Paulo
NCT07318480Recruiting
tDCS for Cocaine Use Disorder

This study tests whether a non-invasive brain stimulation method called tDCS can help reduce cocaine use. You would receive several sessions of mild electrical current applied to your scalp, which may help control cravings and improve your ability to stay abstinent.

New York, New York
NCT07773649Recruiting· Early Phase 1
PET scan to study energy use in brain of people with cocaine use disorder

This study uses a special PET scan to look at how brain cells make energy, which may be changed by cocaine. It might help researchers find better ways to treat cocaine use disorder.

Pittsburgh, Pennsylvania

Hear when a new Cocaine Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.